Abstract B34: Novel synergistic combination therapies with BET bromodomain inhibitors in triple-negative breast cancer
Year: 2018
Type: conference-abstract
Source: Molecular Cancer Research
Institution: University of North Carolina at Chapel Hill
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2885424851
